Compare FEAM & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FEAM | DRIO |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | United States |
| Employees | 35 | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.2M | 60.6M |
| IPO Year | N/A | 2013 |
| Metric | FEAM | DRIO |
|---|---|---|
| Price | $1.57 | $7.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $6.38 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 240.3K | 6.9K |
| Earning Date | 05-20-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | ★ N/A | $6.02 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $1.17 | $0.38 |
| 52 Week High | $7.50 | $17.74 |
| Indicator | FEAM | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 41.67 | 44.48 |
| Support Level | $1.45 | $7.29 |
| Resistance Level | $1.80 | $9.46 |
| Average True Range (ATR) | 0.17 | 0.42 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 6.90 | 46.09 |
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.